Schiz.+Work+cited

Harrison, P. J. (2015). Recent genetic findings in schizophrenia and their therapeutic relevance. Journal of Psychopharmacology, 29(2), 85-96. doi:10.1177/0269881114553647

Hollandsworth, J. G. (2014). The physiology of psychological disorders: schizophrenia, depression, anxiety, and substance abuse. New York: Springer Science Business Media, LLC.

Itokawa, M., Yamada, K., & Yoshitsugu, K. (2003). A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics, 13, 5th ser., 271-278. doi:10.1097/01.fpc.0000054082.64000.63

Strehlow, V., Heyne, H. O., & Lemke, J. R. (2015). The Spectrum of GRIN2A Associated Disorders. Epileptologie, 32, 147-151. Retrieved March 9, 2017. Tsia, G., & Coyle, J. (2002). Glutamatergic Mechanisms in Schizophrenia. Annual Review of Pharmacology and Toxicology, 42, 165-179. doi:10.1146/annurev.pharmtox.42.082701.160735